Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia
Hilde H.F. Remmelts(St. Antonius Ziekenhuis), Douwe H. Biesma(Unknown), Andy I. M. Hoepelman(University Medical Center Utrecht), Rik Heijligenberg(Ziekenhuis Gelderse Vallei), Willem Jan W. Bos(St. Antonius Ziekenhuis), Sabine C A Meijvis(St. Antonius Ziekenhuis), Henrik Endeman(Erasmus MC), Jan C. Grutters(St. Antonius Ziekenhuis), Jan Jelrik Oosterheert(University Medical Center Utrecht), Ger T. Rijkers(Roosevelt University)
Cited by 34
Related Papers
Antibiotic Treatment Strategies for Community-Acquired Pneumonia in Adults
|New England Journal of Medicine|2015|384
Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial
|The Lancet|2011|372
Reconstruction of Brachial Artery Pressure From Noninvasive Finger Pressure Measurements
|Circulation|1996|363
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
|Nature Communications|2021|295
Accuracy of Cuff-Measured Blood Pressure
|Journal of the American College of Cardiology|2017|271